Main Menu
Scientific Member

Contact Site Map Home Links Sponsors Core Resources Research Programs Board of Directors Welcome

Jacques Galipeau MD
Assistant Professor, Departments of Medicine & Oncology, McGill University & Project Director, Lady Davis Institute for Medical Research

 


MAILING ADDRESS

Department of Hematology-Oncology
Jewish General Hospital
3755 Chemin Côte Ste.Catherine
Montréal, Que  H3T 1E2

Telephone:

Laboratory: (514) 340 8222, ext: 5432

Clinic: 514 340-8214

Fax: (514) 340 8281

Email: jgalipea@lab.jgh.mcgill.ca


ACADEMIC BACKGROUND

Degree

Year

Discipline/Field Institution

MD

1983-1988

Faculty of Medicine University of Montreal, Quebec

Internship

1988-1989

Family Medicine Sacre Coeur Hospital, University of Montreal, Quebec

Residency

1989-1992

Internal Medicine Jewish General Hospital, McGill University, Quebec

Fellowship

1992-1995

Hematology/Oncology Tufts University, Boston MA

Post-Doctoral Fellowship

1995-1997

Gene Therapy St-Jude Children’s Research Hospital, Memphis TN


AREAS OF EXPERTISE

Position Held

Institution/Organization

Department/Faculty

Period

Assistant Professor

McGill University

Medicine

1997-present

Assistant Professor

McGill University

Oncology

1997-present

Project Director

Lady Davis Institute

Research

1998-present

Assistant Professor

McGill University

Experimental Medicine

1998-present

Associate Professor

University of Montreal

Microbiology & Pathology

2001-present

Director

Montreal Center for Experimental Therapeutics in Cancer

Cell and Gene Therapy

 


RESEARCH SUPPORT

Principal Applicant

Title of Project

Funding Source and Program

Years of Tenure

J.Galipeau, K. Lachapelle

Therapeutic Angiogenesis by Autologous Marrow Stromal Cells Genetically-engineered to Secrete Erythropoeitin.

Cancer Research Society

1999-2001

J. Galipeau

Fonds d’etablissement pour jeunes chercheurs

FRSQ

2000

Clement Clouture,

J. Galipeau

Identification of a Novel Gene Involved in T Cell Activation by Insertional Mutagenesis

MRC

2000-2003

Bernard Massie,

J. Galipeau

Cancer Gene Therapy; A comprehensive multi-pronged strategy for growth factor targeting.

NCIC Terry Fox New Frontiers operating grant

2000-2003

Jacques Galipeau

Pseudotyped Retrovectors for cell and gene therapy of cancer.

MRC

2000-2004

Rongtuan Lin, 

J. Galipeau

Development of New Class of Immunomodulators that Target Interferon and Cytokine Cascades

CanVac

2000-2004